Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)
National Institutes of Health · Department of Health and Human Services
At a glance
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) is a forecasted federal cooperative agreement opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of November 13, 2026; forecast dates can change. Total estimated funding is $20M across about 3 awards. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.242 (Mental Health Research Grants).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Sep 16, 2026Forecast posted
- Oct 10, 2026 (est.)Full notice expectednext date
- Nov 13, 2026 (est.)Application deadline
- Jul 1, 2027 (est.)Est. award date
- Posted
- Sep 16, 2026
- Est. close date
- Nov 13, 2026
- Est. award date
- Jul 1, 2027
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $20,000,000
- Implied average award
- $6,666,667 calculated
- Expected awards
- 3
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
- Fiscal year
- FY2027
Typical awards for this program (SAM.gov listing for ALN 93.242, not this notice): FY 2023 range: $1 to $17,379,729 Average Cost: $508,267
Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The National Institute of Mental Health (NIMH) intends to publish a Notice of Funding Opportunity (NOFO) to support the development of a research network to study rapid-acting psychotropic interventional drugs (RAPIDs), such as ketamine, esketamine, psilocybin, and other emerging treatments for serious mental illnesses.
Preliminary studies suggest that RAPIDs can produce clinically meaningful improvements in mental health outcomes, in some cases following a single dose. However, important questions remain regarding their effectiveness, safety, durability of benefit, and implementation in routine clinical practice. As these interventions move toward broader use, rigorous real-world evidence is needed to identify how RAPIDs can be delivered safely, effectively, and sustainably across diverse patients, providers, and health care settings.
The primary goal of this NOFO is to generate actionable evidence on the clinical effectiveness, safety, and implementation of RAPIDs. The resulting evidence from this study will help determine how RAPIDs can be safely and effectively integrated into clinical care and may inform future approaches to health care delivery.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.242
Historical data · not a predictionWho was funded under ALN 93.242
Historical data · not a predictionSince October 1, 2023, 7,637 grant awards had funding actions under Mental Health Research Grants, with 5,232 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.
- YALE UNIV$251M
- UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION$201M
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI$141M
- WASHINGTON UNIVERSITY, THE$135M
- UNIVERSITY OF CALIFORNIA, LOS ANGELES$132M
Agency contact (as published)
Division of Services and Intervention Research
NIMHRAPIDS@nih.gov
Please contact via email.
Quick answers
Is this opportunity open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around October 10, 2026. Forecast details and dates can change.
Who is eligible to apply for this opportunity?
The official notice names these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How much funding is available through this opportunity?
Per the notice, total estimated program funding is $20,000,000 and the agency expects to make about 3 awards.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-MH-27-150), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Pilot Effectiveness Trials of Peer Support Services for Suicide Prevention
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Oct 28, 2025 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Oct 11, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Oct 22, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Oct 15, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Jan 7, 2028
- Who can apply
- State governments, County governments, City or township governments and 12 more
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Jan 7, 2028
- Who can apply
- State governments, County governments, City or township governments and 12 more